{"transactions":[{"id":2341971,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2022-03-09T16:50:03.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":2339,"price":70.1,"value":163963.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":62462,"source":{"system":"sec-edgar","filing":"0001645113-22-000025","document":"wf-form4_164686256918260.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511322000025/wf-form4_164686256918260.xml","form_type":"4"}},{"id":2347945,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2022-03-07T18:28:25.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":6106,"price":80.59,"value":492082.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Options to buy 6,106 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":6106,"derivative":{"exercise_price":80.59,"exercise_date":"2023-03-01","expiration_date":"2032-02-29","underlying":"Ordinary Shares","underlying_shares":6106},"source":{"system":"sec-edgar","filing":"0001645113-22-000023","document":"wf-form4_164669568882280.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511322000023/wf-form4_164669568882280.xml","form_type":"4"}},{"id":2347944,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2022-03-07T18:28:25.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":1973,"price":70.407,"value":138913.011,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":64801,"source":{"system":"sec-edgar","filing":"0001645113-22-000023","document":"wf-form4_164669568882280.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511322000023/wf-form4_164669568882280.xml","form_type":"4"}},{"id":2347943,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2022-03-07T18:28:25.000Z","date":"2022-03-03","kind":"sale","acquired":false,"shares":1094,"price":74.498,"value":81500.812,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":66774,"source":{"system":"sec-edgar","filing":"0001645113-22-000023","document":"wf-form4_164669568882280.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511322000023/wf-form4_164669568882280.xml","form_type":"4"}},{"id":2638109,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-07-08T17:26:43.000Z","date":"2021-07-06","kind":"grant","acquired":true,"shares":154,"price":137.122,"value":21116.788,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2021 through June 30, 2021.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2021."}],"balance_after":67868,"source":{"system":"sec-edgar","filing":"0001645113-21-000082","document":"wf-form4_162577957572435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000082/wf-form4_162577957572435.xml","form_type":"4"}},{"id":2797098,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Share Units","published_at":"2021-03-10T16:08:45.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":2404,"price":130.806,"value":314457.624,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":67714,"source":{"system":"sec-edgar","filing":"0001645113-21-000045","document":"wf-form4_161541050375020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000045/wf-form4_161541050375020.xml","form_type":"4"}},{"id":2803310,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Share Units","published_at":"2021-03-08T16:25:38.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":3084,"price":137.554,"value":424216.536,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units vested on March 3, 2021.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":70118,"source":{"system":"sec-edgar","filing":"0001645113-21-000039","document":"wf-form4_161523872602441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000039/wf-form4_161523872602441.xml","form_type":"4"}},{"id":2809001,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-03-04T17:44:45.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":19004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to buy 19,004 ordinary shares will vest and become exercisable in equal installments on each of March 2, 2022, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates."}],"balance_after":19004,"derivative":{"exercise_price":153.09,"expiration_date":"2031-03-01","underlying":"Ordinary Shares","underlying_shares":19004},"source":{"system":"sec-edgar","filing":"0001645113-21-000026","document":"wf-form4_161489786798435.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000026/wf-form4_161489786798435.xml","form_type":"4"}},{"id":2809000,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Share Units","published_at":"2021-03-04T17:44:45.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":10342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units that are scheduled to vest in equal installments on each of March 2, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":73202,"source":{"system":"sec-edgar","filing":"0001645113-21-000026","document":"wf-form4_161489786798435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000026/wf-form4_161489786798435.xml","form_type":"4"}},{"id":2808999,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Share Units","published_at":"2021-03-04T17:44:45.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":2355,"price":152.053,"value":358084.815,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units vested on February 27, 2021.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":62860,"source":{"system":"sec-edgar","filing":"0001645113-21-000026","document":"wf-form4_161489786798435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000026/wf-form4_161489786798435.xml","form_type":"4"}},{"id":2820459,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2021-03-02T16:15:51.000Z","date":"2021-02-27","kind":"exercise","acquired":false,"shares":5555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2021-02-27","underlying":"Ordinary Shares","underlying_shares":5555},"source":{"system":"sec-edgar","filing":"0001645113-21-000023","document":"wf-form4_161471970637754.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000023/wf-form4_161471970637754.xml","form_type":"4"}},{"id":2820458,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-03-02T16:15:51.000Z","date":"2021-02-27","kind":"exercise","acquired":true,"shares":5555,"price":149.1,"value":828250.5,"ownership":{"direct":true},"balance_after":65215,"source":{"system":"sec-edgar","filing":"0001645113-21-000023","document":"wf-form4_161471970637754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000023/wf-form4_161471970637754.xml","form_type":"4"}},{"id":2904467,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"exercise","acquired":false,"shares":36396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F25","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":14.37,"expiration_date":"2025-02-23","underlying":"Ordinary Shares","underlying_shares":36396},"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904466,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":1200,"price":179.301,"value":215161.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F24","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 1,200 shares in multiple trades at prices ranging from $179.10 to $179.60.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":59660,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904465,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":900,"price":178.498,"value":160648.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F23","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 900 shares in multiple trades at prices ranging from $178.10 to $178.98.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":60860,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904464,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":2841,"price":177.331,"value":503797.371,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F22","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 2,841 shares in multiple trades at prices ranging from $177.02 to $177.76.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":61760,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904463,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":400,"price":176.215,"value":70486.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F21","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 400 shares in multiple trades at prices ranging from $175.93 to $176.62.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":64601,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904462,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":2200,"price":175.279,"value":385613.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F20","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 2,200 shares in multiple trades at prices ranging from $174.92 to $175.64.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":65001,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904461,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":2502,"price":174.063,"value":435505.626,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 2,502 shares in multiple trades at prices ranging from $173.72 to $174.69.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":67201,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904460,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":1700,"price":173.1,"value":294270.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 1,700 shares in multiple trades at prices ranging from $172.69 to $173.65.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":69703,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904459,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":11985,"price":171.903,"value":2060257.455,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 11,985 shares in multiple trades at prices ranging from $171.58 to $172.51.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":71403,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904458,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":4826,"price":171.318,"value":826780.668,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 4,826 shares in multiple trades at prices ranging from $170.58 to $171.57.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":83388,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904457,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":2542,"price":169.933,"value":431969.686,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 2,542 shares in multiple trades at prices ranging from $169.55 to $170.51.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":88214,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904456,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":1800,"price":169.194,"value":304549.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 1,800 shares in multiple trades at prices ranging from $168.54 to $169.52.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":90756,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904455,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":3500,"price":167.774,"value":587209.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 3,500 shares in multiple trades at prices ranging from $167.41 to $168.18.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":92556,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904454,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":900,"price":179.368,"value":161431.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 900 shares in multiple trades at prices ranging from $179.22 to $179.70.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":96056,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904453,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":1000,"price":178.675,"value":178675.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 1,000 shares in multiple trades at prices ranging from $178.16 to $179.08.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":96956,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904452,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":2200,"price":177.305,"value":390071.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 2,200 shares in multiple trades at prices ranging from $177.02 to $177.72.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":97956,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904451,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":400,"price":175.981,"value":70392.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 400 shares in multiple trades at prices ranging from $175.69 to $176.38.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":100156,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904450,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":1700,"price":175.136,"value":297731.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 1,700 shares in multiple trades at prices ranging from $174.67 to $175.64.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":100556,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904449,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":1600,"price":173.878,"value":278204.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 1,600 shares in multiple trades at prices ranging from $173.55 to $174.40.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":102256,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904448,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":1300,"price":172.952,"value":224837.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 1,300 shares in multiple trades at prices ranging from $172.51 to $173.20.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":103856,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904447,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":10110,"price":171.859,"value":1737494.49,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 10,110 shares in multiple trades at prices ranging from $171.50 to $172.40.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":105156,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904446,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":2761,"price":171.184,"value":472639.024,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 2,761 shares in multiple trades at prices ranging from $170.50 to $171.49.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":115266,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904445,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":2148,"price":169.76,"value":364644.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 2,148 shares in multiple trades at prices ranging from $169.46 to $170.27.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":118027,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904444,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":800,"price":168.804,"value":135043.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 800 shares in multiple trades at prices ranging from $168.44 to $169.25.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":120175,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904443,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":2499,"price":167.761,"value":419234.739,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 2,499 shares in multiple trades at prices ranging from $167.41 to $168.18.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":120975,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":2904442,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-01-19T17:00:27.000Z","date":"2021-01-15","kind":"exercise","acquired":true,"shares":36396,"price":14.37,"value":523010.52,"ownership":{"direct":true},"balance_after":123474,"source":{"system":"sec-edgar","filing":"0001645113-21-000008","document":"wf-form4_161109361209620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511321000008/wf-form4_161109361209620.xml","form_type":"4"}},{"id":3086665,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2020-07-08T16:24:18.000Z","date":"2020-07-07","kind":"grant","acquired":true,"shares":325,"price":50.405,"value":16381.625,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2020 through June 30, 2020.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2020."}],"balance_after":87078,"source":{"system":"sec-edgar","filing":"0001645113-20-000095","document":"wf-form4_159423984492801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511320000095/wf-form4_159423984492801.xml","form_type":"4"}},{"id":3217942,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Share Units","published_at":"2020-03-10T16:15:32.000Z","date":"2020-03-06","kind":"sale","acquired":false,"shares":2499,"price":69.534,"value":173765.466,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units vested on March 5, 2020.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":86753,"source":{"system":"sec-edgar","filing":"0001645113-20-000047","document":"wf-form4_158387131442466.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511320000047/wf-form4_158387131442466.xml","form_type":"4"}},{"id":3224638,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-03-05T18:50:00.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":37058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 37,058 ordinary shares will vest and become exercisable in equal installments on each of March 3, 2021, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":37058,"derivative":{"exercise_price":69.37,"expiration_date":"2030-03-02","underlying":"Ordinary Shares","underlying_shares":37058},"source":{"system":"sec-edgar","filing":"0001645113-20-000038","document":"wf-form4_158345218296520.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511320000038/wf-form4_158345218296520.xml","form_type":"4"}},{"id":3224637,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Share Units","published_at":"2020-03-05T18:50:00.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":19220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest on March 3, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates."}],"balance_after":89252,"source":{"system":"sec-edgar","filing":"0001645113-20-000038","document":"wf-form4_158345218296520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511320000038/wf-form4_158345218296520.xml","form_type":"4"}},{"id":3238355,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2020-03-02T17:11:56.000Z","date":"2020-02-27","kind":"exercise","acquired":false,"shares":5556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":5555,"derivative":{"exercise_price":0,"exercise_date":"2019-02-27","underlying":"Ordinary Shares","underlying_shares":5556},"source":{"system":"sec-edgar","filing":"0001645113-20-000030","document":"wf-form4_158318709905785.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511320000030/wf-form4_158318709905785.xml","form_type":"4"}},{"id":3238354,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2020-03-02T17:11:56.000Z","date":"2020-02-28","kind":"sale","acquired":false,"shares":2643,"price":72.215,"value":190864.245,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":70032,"source":{"system":"sec-edgar","filing":"0001645113-20-000030","document":"wf-form4_158318709905785.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511320000030/wf-form4_158318709905785.xml","form_type":"4"}},{"id":3238353,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2020-03-02T17:11:56.000Z","date":"2020-02-27","kind":"exercise","acquired":true,"shares":5556,"price":79.45,"value":441424.2,"ownership":{"direct":true},"balance_after":72675,"source":{"system":"sec-edgar","filing":"0001645113-20-000030","document":"wf-form4_158318709905785.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511320000030/wf-form4_158318709905785.xml","form_type":"4"}},{"id":3246504,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2020-02-26T17:14:10.000Z","date":"2020-02-24","kind":"exercise","acquired":false,"shares":21666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2020-02-22","underlying":"Ordinary Shares","underlying_shares":21666},"source":{"system":"sec-edgar","filing":"0001645113-20-000013","document":"wf-form4_158275523372813.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511320000013/wf-form4_158275523372813.xml","form_type":"4"}},{"id":3246503,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2020-02-26T17:14:10.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":8482,"price":81.156,"value":688365.192,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  The sale is mandated by the Issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":67119,"source":{"system":"sec-edgar","filing":"0001645113-20-000013","document":"wf-form4_158275523372813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511320000013/wf-form4_158275523372813.xml","form_type":"4"}},{"id":3246502,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2020-02-26T17:14:10.000Z","date":"2020-02-24","kind":"exercise","acquired":true,"shares":21666,"price":88.26,"value":1912241.16,"ownership":{"direct":true},"balance_after":75601,"source":{"system":"sec-edgar","filing":"0001645113-20-000013","document":"wf-form4_158275523372813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511320000013/wf-form4_158275523372813.xml","form_type":"4"}},{"id":3312604,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2020-01-13T16:09:31.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":35,"price":52.581,"value":1840.335,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2019 through December 31, 2019.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 1, 2019."}],"balance_after":53935,"source":{"system":"sec-edgar","filing":"0001645113-20-000005","document":"wf-form4_157894975363044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000164511320000005/wf-form4_157894975363044.xml","form_type":"4"}},{"id":3421947,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"exercise","acquired":false,"shares":30414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F18","text":"Fully vested as of the date hereof."}],"balance_after":86513,"derivative":{"exercise_price":21.15,"expiration_date":"2028-02-26","underlying":"Ordinary Shares","underlying_shares":30414},"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421946,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"exercise","acquired":false,"shares":56874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F18","text":"Fully vested as of the date hereof."}],"balance_after":97799,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":56874},"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421945,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"exercise","acquired":false,"shares":11632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F18","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":6.72,"expiration_date":"2022-04-29","underlying":"Ordinary Shares","underlying_shares":11632},"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421944,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"exercise","acquired":false,"shares":59520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F18","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":6.72,"expiration_date":"2022-04-29","underlying":"Ordinary Shares","underlying_shares":59520},"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421943,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":1200,"price":89.857,"value":107828.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 1,200 shares in multiple trades at prices ranging from $89.54 to $90.11.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":53900,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421942,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":2900,"price":88.863,"value":257702.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 2,900 shares in multiple trades at prices ranging from $88.53 to $89.36.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":55100,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421941,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":14888,"price":88.178,"value":1312794.064,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 14,888 shares in multiple trades at prices ranging from $87.52 to $88.51.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":58000,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421940,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":11426,"price":86.858,"value":992439.508,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 11,426 shares in multiple trades at prices ranging from $86.40 to $87.24.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":72888,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421939,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"exercise","acquired":true,"shares":30414,"price":21.15,"value":643256.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth."}],"balance_after":84314,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421938,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":4031,"price":89.869,"value":362261.939,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 4,031 shares in multiple trades at prices ranging from $89.54 to $90.32.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":53900,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421937,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":7869,"price":88.973,"value":700128.537,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 7,869 shares in multiple trades at prices ranging from $88.53 to $89.50.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":57931,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421936,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":24083,"price":88.215,"value":2124481.845,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 24,083 shares in multiple trades at prices ranging from $87.52 to $88.51.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":65800,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421935,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":20891,"price":86.954,"value":1816556.014,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 20,891 shares in multiple trades at prices ranging from $86.40 to $87.27.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":89883,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421934,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"exercise","acquired":true,"shares":56874,"price":7.15,"value":406649.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth."}],"balance_after":110774,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421933,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":400,"price":89.969,"value":35987.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 400 shares in multiple trades at prices ranging from $89.79 to $90.18.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":53900,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421932,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":929,"price":88.937,"value":82622.473,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 929 shares in multiple trades at prices ranging from $88.55 to $89.41.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":54300,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421931,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":6065,"price":88.194,"value":534896.61,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 6,065 shares in multiple trades at prices ranging from $87.55 to $88.54.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":55229,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421930,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":4238,"price":86.882,"value":368205.916,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 4,238 shares in multiple trades at prices ranging from $86.49 to $87.25.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":61294,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421929,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"exercise","acquired":true,"shares":11632,"price":6.72,"value":78167.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth."}],"balance_after":65532,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421928,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":2300,"price":89.895,"value":206758.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 2,300 shares in multiple trades at prices ranging from $89.54 to $90.26.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":53900,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421927,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":6616,"price":88.818,"value":587619.888,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 6,616 shares in multiple trades at prices ranging from $88.52 to $89.44.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":56200,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421926,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":28340,"price":88.171,"value":2498766.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 28,340 shares in multiple trades at prices ranging from $87.52 to $88.51.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":62816,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421925,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":22264,"price":86.846,"value":1933539.344,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 22,264 shares in multiple trades at prices ranging from $86.37 to $87.24.  The price reported above reflects the weighted average sale price.  Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":91156,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3421924,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-09-05T16:09:15.000Z","date":"2019-09-03","kind":"exercise","acquired":true,"shares":59520,"price":6.72,"value":399974.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth."}],"balance_after":113420,"source":{"system":"sec-edgar","filing":"0001209191-19-048481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119048481/doc4.xml","form_type":"4"}},{"id":3465254,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-07-09T16:25:01.000Z","date":"2019-07-05","kind":"grant","acquired":true,"shares":696,"price":27.812,"value":19357.152,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2019 through June 30, 2019.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 28, 2019."}],"balance_after":53900,"source":{"system":"sec-edgar","filing":"0001209191-19-041559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119041559/doc4.xml","form_type":"4"}},{"id":3531634,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-05-10T16:15:27.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 20,000 ordinary shares will fully vest and become exercisable on May 8, 2022 if (i) the closing price of the Company's ordinary shares is at least $71.34 for a period of at least twenty (20) consecutive trading days at any time between May 8, 2021 and May 8, 2022 and (ii) Mr. Longsworth has been continuously employed by the Company through May 8, 2022."}],"balance_after":20000,"derivative":{"exercise_price":47.56,"expiration_date":"2029-05-08","underlying":"Ordinary Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-028884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119028884/doc4.xml","form_type":"4"}},{"id":3531633,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-05-10T16:15:27.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":29320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to buy 29,320 ordinary shares will fully vest and become exercisable on May 8, 2022 if (i) the closing price of the Company's ordinary shares is at least $59.45 for a period of at least twenty (20) consecutive trading days at any time between May 8, 2021 and May 8, 2022 and (ii) Mr. Longsworth has been continuously employed by the Company through May 8, 2022."}],"balance_after":29320,"derivative":{"exercise_price":47.56,"expiration_date":"2029-05-08","underlying":"Ordinary Shares","underlying_shares":29320},"source":{"system":"sec-edgar","filing":"0001209191-19-028884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119028884/doc4.xml","form_type":"4"}},{"id":3578486,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-03-26T16:33:42.000Z","date":"2019-03-22","kind":"grant","acquired":true,"shares":29969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 29,969 ordinary shares will vest and become exercisable in equal installments on each of March 5, 2020, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates."}],"balance_after":29969,"derivative":{"exercise_price":47.04,"expiration_date":"2029-03-21","underlying":"Ordinary Shares","underlying_shares":29969},"source":{"system":"sec-edgar","filing":"0001209191-19-021332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119021332/doc4.xml","form_type":"4"}},{"id":3578485,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Share Units","published_at":"2019-03-26T16:33:42.000Z","date":"2019-03-22","kind":"grant","acquired":true,"shares":16369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest on March 5, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates."}],"balance_after":53204,"source":{"system":"sec-edgar","filing":"0001209191-19-021332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119021332/doc4.xml","form_type":"4"}},{"id":3623331,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2019-03-01T16:30:13.000Z","date":"2019-02-27","kind":"exercise","acquired":false,"shares":5556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":11111,"derivative":{"exercise_price":0,"exercise_date":"2019-02-27","underlying":"Ordinary Shares","underlying_shares":5556},"source":{"system":"sec-edgar","filing":"0001209191-19-014989","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119014989/doc4.xml","form_type":"4"}},{"id":3623330,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-03-01T16:30:13.000Z","date":"2019-02-28","kind":"sale","acquired":false,"shares":2368,"price":53.68,"value":127114.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the Issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":36835,"source":{"system":"sec-edgar","filing":"0001209191-19-014989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119014989/doc4.xml","form_type":"4"}},{"id":3623329,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-03-01T16:30:13.000Z","date":"2019-02-27","kind":"exercise","acquired":true,"shares":5556,"price":52.9,"value":293912.4,"ownership":{"direct":true},"balance_after":39203,"source":{"system":"sec-edgar","filing":"0001209191-19-014989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119014989/doc4.xml","form_type":"4"}},{"id":3632434,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2019-02-26T17:54:50.000Z","date":"2019-02-22","kind":"exercise","acquired":false,"shares":21667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":21666,"derivative":{"exercise_price":0,"exercise_date":"2019-02-22","underlying":"Ordinary Shares","underlying_shares":21667},"source":{"system":"sec-edgar","filing":"0001209191-19-013678","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119013678/doc4.xml","form_type":"4"}},{"id":3632433,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-02-26T17:54:50.000Z","date":"2019-02-25","kind":"sale","acquired":false,"shares":9325,"price":53.628,"value":500081.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the Issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":33647,"source":{"system":"sec-edgar","filing":"0001209191-19-013678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119013678/doc4.xml","form_type":"4"}},{"id":3632432,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-02-26T17:54:50.000Z","date":"2019-02-22","kind":"exercise","acquired":true,"shares":21667,"price":53.38,"value":1156584.46,"ownership":{"direct":true},"balance_after":42972,"source":{"system":"sec-edgar","filing":"0001209191-19-013678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119013678/doc4.xml","form_type":"4"}},{"id":3685456,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-01-28T16:15:16.000Z","date":"2019-01-25","kind":"exercise","acquired":false,"shares":11874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable as of the date hereof."}],"balance_after":154673,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":11874},"source":{"system":"sec-edgar","filing":"0001209191-19-005514","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119005514/doc4.xml","form_type":"4"}},{"id":3685455,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-01-28T16:15:16.000Z","date":"2019-01-24","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable as of the date hereof."}],"balance_after":166547,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-005514","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119005514/doc4.xml","form_type":"4"}},{"id":3685454,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-01-28T16:15:16.000Z","date":"2019-01-25","kind":"sale","acquired":false,"shares":11874,"price":50.15,"value":595481.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth."}],"balance_after":21305,"source":{"system":"sec-edgar","filing":"0001209191-19-005514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119005514/doc4.xml","form_type":"4"}},{"id":3685453,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-01-28T16:15:16.000Z","date":"2019-01-25","kind":"exercise","acquired":true,"shares":11874,"price":7.15,"value":84899.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth."}],"balance_after":33179,"source":{"system":"sec-edgar","filing":"0001209191-19-005514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119005514/doc4.xml","form_type":"4"}},{"id":3685452,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-01-28T16:15:16.000Z","date":"2019-01-24","kind":"sale","acquired":false,"shares":15000,"price":48.15,"value":722250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth."}],"balance_after":21305,"source":{"system":"sec-edgar","filing":"0001209191-19-005514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119005514/doc4.xml","form_type":"4"}},{"id":3685451,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-01-28T16:15:16.000Z","date":"2019-01-24","kind":"exercise","acquired":true,"shares":15000,"price":7.15,"value":107250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth."}],"balance_after":36305,"source":{"system":"sec-edgar","filing":"0001209191-19-005514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119005514/doc4.xml","form_type":"4"}},{"id":3691860,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-01-18T16:12:13.000Z","date":"2019-01-16","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable as of the date hereof."}],"balance_after":181547,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-004546","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119004546/doc4.xml","form_type":"4"}},{"id":3691859,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-01-18T16:12:13.000Z","date":"2019-01-16","kind":"sale","acquired":false,"shares":15000,"price":45.15,"value":677250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth."}],"balance_after":21305,"source":{"system":"sec-edgar","filing":"0001209191-19-004546","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119004546/doc4.xml","form_type":"4"}},{"id":3691858,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-01-18T16:12:13.000Z","date":"2019-01-16","kind":"exercise","acquired":true,"shares":15000,"price":7.15,"value":107250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth."}],"balance_after":36305,"source":{"system":"sec-edgar","filing":"0001209191-19-004546","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119004546/doc4.xml","form_type":"4"}},{"id":3697436,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-01-11T16:21:53.000Z","date":"2019-01-09","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable as of the date hereof."}],"balance_after":196547,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-003417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119003417/doc4.xml","form_type":"4"}},{"id":3697435,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-01-11T16:21:53.000Z","date":"2019-01-09","kind":"sale","acquired":false,"shares":15000,"price":40.15,"value":602250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth."}],"balance_after":21305,"source":{"system":"sec-edgar","filing":"0001209191-19-003417","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119003417/doc4.xml","form_type":"4"}},{"id":3697434,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2019-01-11T16:21:53.000Z","date":"2019-01-09","kind":"exercise","acquired":true,"shares":15000,"price":7.15,"value":107250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth."}],"balance_after":36305,"source":{"system":"sec-edgar","filing":"0001209191-19-003417","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919119003417/doc4.xml","form_type":"4"}},{"id":3870407,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2018-07-10T16:12:46.000Z","date":"2018-07-06","kind":"grant","acquired":true,"shares":1231,"price":17.255,"value":21240.905,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2018 through June 30, 2018.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 2, 2018."}],"balance_after":21305,"source":{"system":"sec-edgar","filing":"0001209191-18-042140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919118042140/doc4.xml","form_type":"4"}},{"id":4024097,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Unit","published_at":"2018-03-01T16:22:35.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates."}],"balance_after":16667,"derivative":{"underlying":"Ordinary Shares","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001209191-18-015016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919118015016/doc4.xml","form_type":"4"}},{"id":4024096,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Options to Buy Ordinary Shares","published_at":"2018-03-01T16:22:35.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":121655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to buy 121,655 ordinary shares will vest and become exercisable in equal installments on each of February 27, 2019, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates."}],"balance_after":121655,"derivative":{"exercise_price":21.15,"expiration_date":"2028-02-27","underlying":"Ordinary Shares","underlying_shares":121655},"source":{"system":"sec-edgar","filing":"0001209191-18-015016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919118015016/doc4.xml","form_type":"4"}},{"id":4034137,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":129320,"kind":"person","name":"Longsworth Todd Christopher","position":1,"cik":"0001693530","reported_name":"Longsworth Todd Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2018-02-26T17:14:40.000Z","date":"2018-02-22","kind":"exercise","acquired":true,"shares":21667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":43333,"derivative":{"exercise_price":0,"exercise_date":"2018-02-22","underlying":"Ordinary Shares","underlying_shares":21667},"source":{"system":"sec-edgar","filing":"0001209191-18-013433","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693530/000120919118013433/doc4.xml","form_type":"4"}}],"next_cursor":"2018-02-26T17:14:40.000000Z,4034137"}